logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울중앙지방법원 2018.06.20 2018나1369
보험금
Text

1. The plaintiff and the defendant against the defendant exceeding the amount ordered to be paid under the judgment of the first instance.

Reasons

1. The court's explanation on this part of the basic facts is identical to the corresponding part of the reasoning of the judgment of the first instance (1. 1.). Thus, this part is cited by the main sentence of Article 420 of the Civil Procedure Act.

2. The parties' assertion and judgment

A. The main point of the party's assertion (i) The plaintiff was confirmed diagnosis for cancer falling under C20 under the classification number of C20 under the Korea Standard Disease Disease Death Classification as amended, as to the species of this case. Thus, the defendant was entitled to KRW 30,000,000 under the insurance contract of this case and KRW 2,000,000, and KRW 72,000,000, which are the aggregate of KRW 30,000,000 (= KRW 30,000,000 + KRW 40,000 + KRW 40,000,0000 + KRW 15,000, KRW 000 under the insurance contract of this case, KRW 10,000, KRW 1000, KRW 1000, KRW 4000, KRW 5,0000 under the insurance contract of this case). The plaintiff actually received the diagnosis benefit of this case from the defendant under the insurance contract of this case

(i) the remainder of KRW 57,000,000 (=72,000,000 - 15,000,000) after deducting Company and damages for delay shall be paid.

B. The species of the instant case are khionod khiond in the place of work, which does not turn to the blood ties with any other body parts or tissues than the place of work, and thus fall under the Korean Standard Disease Disease Classification stipulated in the 1 and 2 insurance contract, and do not fall under cancer. Thus, the Defendant does not have any reason to respond to the Plaintiff’s claim.

B. (1) Insurance accidents or causes for the payment of insurance proceeds, which are a major part of the relevant insurance contract, are generally accepted.

arrow